Fast Market Research

Edgemont Pharmaceuticals, LLC - Product Pipeline Review - 2013 - New Report Available

New Pharmaceuticals market report from Global Markets Direct: "Edgemont Pharmaceuticals, LLC - Product Pipeline Review - 2013"


Boston, MA -- (SBWIRE) -- 02/11/2014 -- Global Market Direct's pharmaceuticals report, "Edgemont Pharmaceuticals, LLC - Product Pipeline Review - 2013" provides data on the Edgemont Pharmaceuticals, LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Edgemont Pharmaceuticals, LLC's corporate website, SEC filings, investor presentations and featured press releases, both from Edgemont Pharmaceuticals, LLC and industry-specific third party sources, put together by Global Markets Direct's team.


- Edgemont Pharmaceuticals, LLC - Brief Edgemont Pharmaceuticals, LLC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Edgemont Pharmaceuticals, LLC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Edgemont Pharmaceuticals, LLC with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Edgemont Pharmaceuticals, LLC's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Edgemont Pharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Edgemont Pharmaceuticals, LLC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Edgemont Pharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Edgemont Pharmaceuticals, LLC.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Edgemont Pharmaceuticals, LLC and identify potential opportunities in those areas.

Companies Mentioned in this Report: Edgemont Pharmaceuticals, LLC

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Deciphera Pharmaceuticals, LLC - Product Pipeline Review - 2013
- CureFAKtor Pharmaceuticals. LLC - Product Pipeline Review - 2013
- High Point Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Kinex Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Iroko Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Foresee Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Nexgenix Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Arrien Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Lymphoma - Pipeline Review, H2 2013
- Prostate Cancer - Pipeline Review, H2 2013